Marco Quarta, PhD

Founder & Chief Scientific Officer
Rubedo Life Sciences

Biography

Marco Quarta is a scientist, entrepreneur, and biotechnology executive dedicated to advancing the science of aging and regenerative medicine. He is the founding Chief Executive Officer and current Chief Scientific Officer of Rubedo Life Sciences, a company pioneering new classes of therapeutics designed to selectively target senescent cells and other key mechanisms of age-related disease.
From 2008 to 2018, Dr. Quarta was a leading scientist at Stanford University, where he directed research and development at the Center for Tissue Regeneration, Repair, and Restoration of the VA Hospital in Palo Alto, in collaboration with the Stanford School of Medicine. At Stanford, he built and led a translational program in regenerative medicine, bridging discoveries in stem cell biology and tissue repair with clinical applications in aging and chronic disease.

He has authored more than 40 peer-reviewed publications and patents spanning aging biology, stem cells, regenerative medicine, and cellular rejuvenation. Dr. Quarta has also played a key role in biotechnology entrepreneurship, co-founding Turn Biotechnologies, Wetware Concepts, and YEBN, and serving on the Executive Board of the European Federation of Biotechnology.
Currently, Dr. Quarta is a member of the Paul F. Glenn Center for the Biology of Aging Studies at Stanford University, serves on the Advisory Board of the California Institute for Regenerative Medicine (CIRM) Cal Poly Bridge Program, and on the Advisory Board of the Center for Healthcare Innovation. He is also the President and co-founder of the Phaedon Institute, a non-profit scientific organization dedicated to advancing Longevity Medicine, fostering dialogue between academia, industry, and healthcare systems on the future of aging therapeutics.